Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- Reimbursement of Generic Drugs Used Off-Label “Not Necessarily Illegal,” Government Says
September 20, 2012
- Half of Hospitals Participating in Network Play Central Role: MHLW FY2011 Survey
September 19, 2012
- MHLW Eyes Introduction of Piecework Payment for Clinical Trials at 54 Hospitals by FY2016
September 18, 2012
- MHLW Budget Request Includes Funds for Database of Information on Patients with Cancer, Lifestyle Diseases
September 18, 2012
- MHLW Calls for Self-Inspections at Japanese Pharmaceutical Firms after “Gutter Oil”-Made Antibiotic Intermediates Found in China
September 14, 2012
- MHLW Instructs Daiichi Sankyo to Issue Blue Letter on Ranmark Following Two Reported Deaths
September 13, 2012
- MEXT Calls for 21 Billion Yen for Special Priority Area of Healthcare Innovation in FY2013 Budget Request
September 12, 2012
- Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27
September 12, 2012
- MHLW Issues Q&As on Drug Risk Management Plans to Prefectures
September 12, 2012
- MHLW Notifies of Expected Additional Indications for 3 APIs
September 12, 2012
- PAFSC’s 2nd Committee Designates 7 products as Orphan Drugs Including Glioblastoma Treatment Bevacizumab
September 11, 2012
- Chairman Breaks Tie, Votes to Continue Lower House Discussions on Bill to Establish 3rd-Party Organization
September 11, 2012
- MHLW’s FY2013 Budget Request Includes Funding to Set Up Municipal Generic Drug Promotion Councils
September 11, 2012
- PAFSC 2nd Committee Recommends Approval for Novartis’s COPD Drug
September 11, 2012
- DPJ’s Project Team Concerned that Participation in TPP Agreement Could Interfere with Japan’s Industrial Policies
September 10, 2012
- MHLW to Study Overseas Generic Drug Markets to Support Globalization of Domestic Industry
September 10, 2012
- “Some Problems” Found with UMN Pharma’s Cell Culture Method Development Project: MHLW
September 7, 2012
- Labor Standards Bureau Head Junichi Kaneko to Be Appointed Vice Minister of Health; Pension Bureau Head Jun Ebata to Be Transferred to PFSB: MHLW
September 6, 2012
- MHLW to Request 41.1 Bil. Yen in FY2013 Budget for Drug Discovery Support and Other Special Priority Projects
September 6, 2012
- Project to Develop Vaccines for New Influenza Strains Using Chicken Egg Culture Method Receives “A” Grade: MHLW
September 4, 2012
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…